Alireza Ansarimoghaddam1, Hosein Ali Adineh2, Iraj Zareban1, Sohrab Iranpour3, Ali HosseinZadeh4, Framanfarma Kh5. 1. Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. 2. Iranshahr University of Medical Sciences, Iranshahr, Iran. Electronic address: payam.health@yahoo.com. 3. Department of Epidemiology and Biostatistics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 4. Department of Epidemiology and Biostatistics, Kerman University of Medical Sciences, Kerman, Iran. 5. Department of epidemiology and biostatistics, School of Health, Zahedan university of medical sciences, Zahedan, Iran.
Abstract
OBJECTIVE: Metabolic syndrome is an important metabolic disorder which impose noticeable burden on health system. We aimed to review and imply the prevalence of it in Middle-East countries. METHODS: present study was a systematic review to present overview about metabolic disorder in Middle East. Electronic literature search of Medline database and Google scholar were done for English-language articles without time filtering, as well as for population-based or national studies of the prevalence of metabolic syndrome. The fallowing search terms were used simultaneously: prevalence of "metabolic syndrome" and "national study", "prevalence of metabolic syndrome in Middle East", "prevalence of metabolic syndrome" and "name of country", "metabolic syndrome &name of country". Additionally, relevant articles in bibliography were searched. Analysis of data was carried out in STATA version 11.0. RESULTS: out of 456 studies in first-step searching (selecting by title) 59 studies were recruited and reviewed. Prevalence of metabolic syndrome fluctuated by country and time of study. This amount was 2.2-44% in Turkish, 16-41% in Saudi-Arabia, 14-63 in Pakistan, 26-33 in Qatar, 9-36 in Kuwait, 22-50 in Emirate, 6-42 in Iran, and up to 23 in Yemen. Pooled estimate was 25%. Attributable risk for cardiovascular disease, coronary heart disease, and stroke was 15.87, 11.7, and 16.23, respectively. CONCLUSION: The prevalence rate of metabolic syndrome is high and it is noticeable cause for stroke, coronary heart disease, and cardiovascular disease.
OBJECTIVE:Metabolic syndrome is an important metabolic disorder which impose noticeable burden on health system. We aimed to review and imply the prevalence of it in Middle-East countries. METHODS: present study was a systematic review to present overview about metabolic disorder in Middle East. Electronic literature search of Medline database and Google scholar were done for English-language articles without time filtering, as well as for population-based or national studies of the prevalence of metabolic syndrome. The fallowing search terms were used simultaneously: prevalence of "metabolic syndrome" and "national study", "prevalence of metabolic syndrome in Middle East", "prevalence of metabolic syndrome" and "name of country", "metabolic syndrome &name of country". Additionally, relevant articles in bibliography were searched. Analysis of data was carried out in STATA version 11.0. RESULTS: out of 456 studies in first-step searching (selecting by title) 59 studies were recruited and reviewed. Prevalence of metabolic syndrome fluctuated by country and time of study. This amount was 2.2-44% in Turkish, 16-41% in Saudi-Arabia, 14-63 in Pakistan, 26-33 in Qatar, 9-36 in Kuwait, 22-50 in Emirate, 6-42 in Iran, and up to 23 in Yemen. Pooled estimate was 25%. Attributable risk for cardiovascular disease, coronary heart disease, and stroke was 15.87, 11.7, and 16.23, respectively. CONCLUSION: The prevalence rate of metabolic syndrome is high and it is noticeable cause for stroke, coronary heart disease, and cardiovascular disease.
Authors: Kumaraswamy Naidu Chitrala; Dena G Hernandez; Michael A Nalls; Nicolle A Mode; Alan B Zonderman; Ngozi Ezike; Michele K Evans Journal: Epigenetics Date: 2019-12-04 Impact factor: 4.528
Authors: Eva-Maria Navarrete-Muñoz; Jesus Vioque; Estefanía Toledo; Alejando Oncina-Canovas; Miguel Ángel Martínez-González; Jordi Salas-Salvadó; Dolores Corella; Montserrat Fitó; Dora Romaguera; Ángel M Alonso-Gómez; Julia Wärnberg; J Alfredo Martínez; Luís Serra-Majem; Ramon Estruch; Francisco J Tinahones; José Lapetra; Xavier Pintó; Josep A Tur; José López-Miranda; Aurora Bueno-Cavanillas; Pilar Matía-Martín; Lidia Daimiel; Vicente Martín Sánchez; Josep Vidal; Ana Isabel de Cos Blanco; Emili Ros; Javier Diez-Espino; Nancy Babio; Rebeca Fernandez-Carrion; Olga Castañer; Antoni Colom; Laura Compañ-Gabucio; Itziar Salaverria Lete; Edelys Crespo-Oliva; Itziar Abete; Laura Tomaino; Rosa Casas; José Carlos Fernandez-Garcia; José Manuel Santos-Lozano; Iziar Sarasa; José M Gámez; José M Antonio Garcia-Rios; Sandra Martín-Pelaez; Miguel Ruiz-Canela; Andrés Díaz-López; Raul Martinez-Lacruz; Maria Dolors Zomeño; Elena Rayó; Cristina Gisbert Sellés; Silvia Canudas; Albert Goday; Manoli García-de-la-Hera Journal: Eur J Nutr Date: 2020-08-24 Impact factor: 5.614
Authors: Muhammad Ikram Ullah; Badr Alzahrani; Abdullah Alsrhani; Muhammad Atif; Ayman Ali Mohammed Alameen; Hasan Ejaz Journal: Pak J Med Sci Date: 2021 May-Jun Impact factor: 1.088
Authors: Grzegorz Józef Nowicki; Barbara Ślusarska; Katarzyna Naylor; Andrzej Prystupa; Ewa Rudnicka-Drożak; Ulyana Halyuk; Petro Pokotylo Journal: Diabetes Metab Syndr Obes Date: 2021-05-06 Impact factor: 3.168
Authors: Abdulrahman O Alomar; Mohammed F Shaheen; Abdallh S Almaneea; Eyad K Althaqeb; Ziyad M Alshahrani; Yazeed A Jarman; Sultan Alhabdan Journal: Obes Surg Date: 2021-05-27 Impact factor: 4.129